Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii

The induction by IFN-γ of reactive nitrogen intermediates has been postulated as a major mechanism of host resistance to intracellular pathogens. To formally test this hypothesis in vivo, the course of Toxoplasma gondii infection was assessed in nitric oxide synthase (iNOS)−/− mice. As expected, macrophages from these animals displayed defective microbicidal activity against the parasite in vitro. Nevertheless, in contrast to IFN-γ−/− or IL-12 p40−/− animals, iNOSdeficient mice survived acute infection and controlled parasite growth at the site of inoculation. This early resistance was ablated by neutralization of IFN-γ or IL-12 in vivo and markedly diminished by depletion of neutrophils, demonstrating the existence of previously unappreciated NO independent mechanisms operating against the parasite during early infection. By 3-4 wk post infection, however, iNOS knockout mice did succumb to T. gondii. At that stage parasite expansion and pathology were evident in the central nervous system but not the periphery suggesting that the protective role of nitric oxide against this intracellular infection is tissue specific rather than systemic.

[1]  A. Sher,et al.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. , 1996, Journal of immunology.

[2]  Y. Suzuki,et al.  IL-4 is protective against development of toxoplasmic encephalitis. , 1996, Journal of immunology.

[3]  D. Carvajal,et al.  IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .

[4]  V. Poli,et al.  Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans , 1996, The Journal of experimental medicine.

[5]  C. Bogdan,et al.  Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase , 1996, The Journal of experimental medicine.

[6]  R. Gazzinelli,et al.  Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. , 1996, Journal of immunology.

[7]  I. Khan,et al.  Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. , 1996, Journal of immunology.

[8]  E. Unanue,et al.  Listeria monocytogenes induces apoptosis of infected hepatocytes. , 1996, Journal of immunology.

[9]  S. James Role of nitric oxide in parasitic infections. , 1995, Microbiological reviews.

[10]  C. Hunter,et al.  The role of IL12 in toxoplasmosis. , 1995, Research in immunology.

[11]  S. Holland,et al.  The p47phox mouse knock-out model of chronic granulomatous disease , 1995, Journal of Experimental Medicine.

[12]  I. Charles,et al.  Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.

[13]  C. Nathan,et al.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.

[14]  Johnson Ll,et al.  Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii infection. , 1995 .

[15]  G. Trinchieri,et al.  Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in mice , 1995, European journal of immunology.

[16]  M. Burdick,et al.  Interferon gamma modulates the expression of neutrophil-derived chemokines. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[17]  F. Cunha,et al.  Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro , 1994, Infection and immunity.

[18]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[19]  A. Sher,et al.  Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. , 1994, Journal of immunology.

[20]  J. Heesemann,et al.  Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion , 1994, Infection and immunity.

[21]  C. Hunter,et al.  Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates , 1994, Infection and immunity.

[22]  I. Khan,et al.  Interleukin-12 enhances murine survival against acute toxoplasmosis , 1994, Infection and immunity.

[23]  M. Washington,et al.  Nitric oxide produced during murine listeriosis is protective , 1994, Infection and immunity.

[24]  E. Unanue,et al.  Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice , 1993, Infection and immunity.

[25]  A. Sher,et al.  Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice , 1993, The Journal of experimental medicine.

[26]  A. Sher,et al.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. , 1993, Journal of immunology.

[27]  A. Martella,et al.  Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. , 1993, Clinical immunology and immunopathology.

[28]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[29]  E. Unanue,et al.  Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. , 1993, Journal of immunology.

[30]  A. Sher,et al.  The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β , 1992, European journal of immunology.

[31]  A. Sher,et al.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.

[32]  M. Fresno,et al.  Synergism between tumor necrosis factor‐α and interferon‐γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide‐dependent mechanism , 1992 .

[33]  L. Fransen,et al.  IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. , 1992, Journal of immunology.

[34]  J. Woodman,et al.  Human endothelial cells are activated by IFN-gamma to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. , 1991, Journal of immunology.

[35]  J. W. Conlan,et al.  Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium , 1991, The Journal of experimental medicine.

[36]  D. Longo,et al.  Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. , 1991, Journal of immunology.

[37]  Y. Buchmüller‐Rouiller,et al.  Journal of Leukocyte Biology 49:73-82 (1991) Killing of Leishmania Parasites in Activated Murine Macrophages is Based on an L-Arginine-Dependent Process That Produces Nitrogen Derivatives , 2022 .

[38]  F. Liew,et al.  Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. , 1990, Journal of immunology.

[39]  Y. Suzuki,et al.  Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon , 1990, Infection and Immunity.

[40]  S. Moncada,et al.  Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. , 1990, Journal of immunology.

[41]  J. Hibbs,et al.  Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. , 1990, Journal of immunology.

[42]  J. Schwartzman,et al.  Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts , 1990, Infection and immunity.

[43]  M. Meltzer,et al.  Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. , 1990, Journal of immunology.

[44]  S. James,et al.  Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. , 1989, Journal of immunology.

[45]  Y. Suzuki,et al.  Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. , 1989, Journal of immunology.

[46]  H. R. Chang,et al.  Macrophage oxidative metabolism and intracellular Toxoplasma gondii. , 1989, Microbial pathogenesis.

[47]  H. Murray,et al.  Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages , 1989, Infection and immunity.

[48]  R. Coffman,et al.  The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. , 1988, Journal of Immunology.

[49]  R. Schreiber,et al.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. , 1988, Science.

[50]  T. Mosmann,et al.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies , 1987, The Journal of experimental medicine.

[51]  C. Black,et al.  Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages , 1987, Infection and immunity.

[52]  R. Werk How does Toxoplasma gondii enter host cells? , 1985, Reviews of infectious diseases.

[53]  H. Murray,et al.  Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. , 1985, Journal of immunology.

[54]  B. Luft,et al.  Effect of murine interferon gamma on murine toxoplasmosis. , 1984, The Journal of infectious diseases.

[55]  C. Czuprynski,et al.  Killing of Listeria monocytogenes by Inflammatory Neutrophils and Mononuclear Phagocytes From Immune and Nonimmune Mice , 1984, Journal of leukocyte biology.

[56]  E. Pfefferkorn Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[57]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[58]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[59]  T. Khavkin Histological and ultrastructural studies of the interaction of Toxoplasma gondii Tachyzoites with mouse omentum in experimental infection. , 1981, The Journal of protozoology.

[60]  V. Tsai,et al.  Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens , 1980, The Journal of experimental medicine.

[61]  C. Wilson,et al.  Activity of human blood leukocytes against Toxoplasma gondii. , 1979, The Journal of infectious diseases.

[62]  H. Murray,et al.  Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates , 1979, The Journal of experimental medicine.

[63]  C. Nathan,et al.  Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates , 1979, The Journal of experimental medicine.

[64]  R. McLeod,et al.  A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen. , 1979, Journal of immunological methods.

[65]  E. Sadun,et al.  Immunology of Parasitic Infections , 1977 .

[66]  E. Pfefferkorn,et al.  Specific labeling of intracellular Toxoplasma gondii with uracil. , 1977, The Journal of protozoology.

[67]  J. Remington,et al.  A Role for Activated Macrophages in Resistance to Infection with Toxoplasma , 1972, Infection and immunity.

[68]  A. Sher,et al.  Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.

[69]  D. Carvajal,et al.  IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. , 1996, Immunity.

[70]  L. Johnson,et al.  Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii infection. , 1995, Natural immunity.